Cannabis play Creso Pharma (AX:CPH) has announced its Canadian subsidiary, Mernova Medicinal Inc. has entered into an agreement with CannDelta, a leading North American regulatory and scientific cannabis consulting agency.
The collaboration will enable Mernova to navigate the European Good Manufacturing Practice (EU GMP) licensing process for its manufacturing facility in Nova Scotia, Canada.
Obtaining an EU GMP licence will enable Mernova to expand its international presence and tap into new markets that offer higher-margin opportunities.
Initially, Mernova will target the Australian market, which commands prices twice as high as Canada’s for cannabis on a per gram sales basis.
Read full story at source:
